Response of CDA type I to alpha-interferon.
Wickramasinghe
S N
SN
D000328:Adult; D000742:Anemia, Dyserythropoietic, Congenital / Q000097:blood / Q000473:pathology / Q000628:therapy*; D001663:Bilirubin / Q000097:blood; D001853:Bone Marrow / Q000473:pathology; D004911:Erythrocyte Volume; D005260:Female; D006412:Hematopoietic Stem Cells / Q000473:pathology / Q000648:ultrastructure; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008854:Microscopy, Electron; D011994:Recombinant Proteins; D013154:Spleen / Q000033:anatomy & histology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D007770:L-Lactate Dehydrogenase; D001663:Bilirubin